These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36177005)

  • 1. A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL).
    Tanaka Y; Tanaka R; Imaizumi N; Mizuguchi M; Takahashi Y; Hayashi M; Miyagi T; Uchihara J; Ohshiro K; Masuzaki H; Fukushima T
    Front Immunol; 2022; 13():921606. PubMed ID: 36177005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.
    Tanaka Y; Takahashi Y; Tanaka R; Kodama A; Fujii H; Hasegawa A; Kannagi M; Ansari AA; Saito M
    AIDS Res Hum Retroviruses; 2014 Jun; 30(6):542-52. PubMed ID: 24524420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
    Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer activity and antibody-dependent cellular cytotoxicity in patients with adult T-cell leukemia.
    Uno H; Kawano K; Matsuoka H; Tsuda K
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):730-9. PubMed ID: 2618548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1.
    Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S
    J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Innate-Immune-Cell-Based Immunotherapy for Adult T-Cell Leukemia-Lymphoma.
    Nakashima M; Tanaka Y; Okamura H; Kato T; Imaizumi Y; Nagai K; Miyazaki Y; Murota H
    Cells; 2024 Jan; 13(2):. PubMed ID: 38247820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.
    Takamori A; Hasegawa A; Utsunomiya A; Maeda Y; Yamano Y; Masuda M; Shimizu Y; Tamai Y; Sasada A; Zeng N; Choi I; Uike N; Okamura J; Watanabe T; Masuda T; Kannagi M
    Retrovirology; 2011 Dec; 8():100. PubMed ID: 22151736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody to the central region of human T-lymphotropic virus type 1 gp46 is associated with the progression of adult T-cell leukemia.
    Sagara Y; Inoue Y; Ohshima K; Kojima E; Utsunomiya A; Tsujimura M; Shiraki H; Kashiwagi S
    Cancer Sci; 2007 Feb; 98(2):240-5. PubMed ID: 17297657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals.
    Plotnicky-Gilquin H; Afani A; Vernant JC; Desgranges C
    Clin Exp Immunol; 1996 Jul; 105(1):39-45. PubMed ID: 8697633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
    Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating mRNA expression of tax, B chain of PDGF and PDGF-β receptors as well as HTLV-I proviral load in ATL patients and healthy carriers.
    Atabati H; Esmaeili SA; Allahyari A; Shirdel A; Rahimi H; Rezaee SA; Momtazi-Borojeni AA; Rafatpanah H
    J Med Virol; 2021 Jun; 93(6):3865-3870. PubMed ID: 32918495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
    Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
    Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIR3DL2 contributes to the typing of acute adult T-cell leukemia and is a potential therapeutic target.
    Cheminant M; Lhermitte L; Bruneau J; Sicard H; Bonnafous C; Touzart A; Bourbon E; Ortonne N; Genestier L; Gaulard P; Palmic P; Suarez F; Frenzel L; Naveau L; Bazarbachi A; Dussiot M; Waast L; Avettand-Fenoel V; Brouzes C; Pique C; Lepelletier Y; Asnafi V; Marçais A; Hermine O
    Blood; 2022 Sep; 140(13):1522-1532. PubMed ID: 35687761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralizing human monoclonal antibodies to conformational epitopes of human T-cell lymphotropic virus type 1 and 2 gp46.
    Hadlock KG; Rowe J; Perkins S; Bradshaw P; Song GY; Cheng C; Yang J; Gascon R; Halmos J; Rehman SM; McGrath MS; Foung SK
    J Virol; 1997 Aug; 71(8):5828-40. PubMed ID: 9223472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
    Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
    Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.
    Saito M; Tanaka R; Fujii H; Kodama A; Takahashi Y; Matsuzaki T; Takashima H; Tanaka Y
    Retrovirology; 2014 Aug; 11():74. PubMed ID: 25163482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
    Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
    Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.